Article Text
PostScript
Letter
Vedolizumab safety in pregnancy and newborn outcomes
Statistics from Altmetric.com
Footnotes
Contributors DCB wrote the first draft. All authors edited and approved the final manuscript.
Competing interests MJ, JK and DCB have served as paid speakers on medical education events supported by and/or scientific advisors to Takeda, manufacturer of vedolizumab.
Patient consent Obtained.
Ethics approval Patients granted approval.
Provenance and peer review Not commissioned; internally peer reviewed.
Data sharing statement This data can be shared according to international guidelines.